146 Publications (Page 6 of 6)
2007
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
O’Connor, R.O’Leary, M.Ballot, J.Collins, C.D.Kinsella, P.Mager, D.E.Arnold, R.D.O’Driscoll, L.Larkin, A.Kennedy, S.Fennelly, D.Clynes, M. and Crown, J.
Cancer Chemotherapy and Pharmacology, vol. 59, pp. 79-87. | Journal Article
 
Biotechnology-Derived Drug Product Development
Carl, S.M.Lindley, D.J.Knipp, G.T.Morris, K.R.Oliver, E.Becker, G.W. and Arnold, R.D.
2007
2006
A Phase 1 clinical and pharmacokinetic study of the Multidrug Resistance Protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer
O'Conner, RO'Leary, M.O., Ballot, R., Collins, C., Kinsella, P., Mager, D.M., Arnold, R.D., O'Driscoll, L.O., Larkin, A.M., Kennedy, S., Fennelly, D., Clynes, M., and Crown, J. and Arnold, Robert D
Cancer Chemotherapy and Pharmacology, 2006. | Journal Article
2005
Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution
Arnold, Robert DMager, D.E.Slack, J.E. and Straubinger, R.M
Clinical Cancer Research, 2005. | Journal Article
 
Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
Arnold, RobertArnold, Robert DMager, DonaldMager, Donald ESlack, Jeanine ESlack, JeanineStraubinger, Robert and Straubinger, Robert M
Clinical Cancer Research, vol. 11, (no. 24), pp. 8856-8865, 2005. | Journal Article
 
Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model
Arnold, RobertArnold, Robert DMager, DonaldMager, Donald ESlack, Jeanine ESlack, JeanineStraubinger, Robert and Straubinger, Robert M
Clinical Cancer Research, vol. 11, (no. 24), pp. 8865, 20051215. | Journal Article
 
Tumor antivascular effects of sterically-stabilized doxorubicin-containing liposomes
Arnold, R.D.,Mager, D.E., Spernyak, J.A., Mazurchuk, R.V., Straubinger, R. and Arnold, Robert D
AACR National Meeting, Anaheim, CA.. 2005. | Conference Proceeding
2004
Altered plasma pharmacokinetics, tumor/tissue biodistribution, and barrier properties of the tumor microvasculature in rats following repetitive dosing of doxorubicin liposomes
Arnold, R.D.,Slack, J.E., Mager, D.E., R., Spernyak, J., Mazurchuk, R., Straubinger, R. and Arnold, Robert D
Advances in Liposomes: New Technologies and New Therapies, Chicago, IL. 2004. | Conference Proceeding
 
Antivascular and antitumor activities of liposome-associated drugs
Straubinger RMArnold, Robert DZhou RMazurchuk R and Slack JE
Anticancer Research, vol. 24, (no. 2A), pp. 397-404, Mar-Apr 2004. | Journal Article
 
Antivascular and antitumor activities of liposome-associated drugs.
Straubinger, Robert MArnold, Robert DZhou, RongMazurchuk, Richard and Slack, Jeanine E
Anticancer research, vol. 24, (no. 2A), pp. 397-404, 2004 Mar-Apr. | Journal Article
 
Antivascular and Antitumor Activities of Liposome-associated Drugs
Straubinger, Robert MArnold, Robert DZhou, R.Mazurchuk, R. and Slack, JE
Anticancer Research, vol. 24, (no. 2A), pp. 397-404, 2004. | Journal Article
 
Effect of repetitive administration of doxorubicin encapsulated in sterically stabilized liposomes on plasma kinetics, brain tumor/tissue drug deposition, and tumor vascular permeability in Rats
Arnold, R.D.,Slack, J.E., Mager, D.E., and Straubinger R.M. and Arnold, Robert D
AACR National Meeting, Orlando, FL. 2004. | Conference Proceeding
 
Increased brain tumor deposition of doxorubicin liposomes following repetitive dosing: alterations in plasma pharmacokinetics and barrier properties of the tumor microvasculature in rats
Arnold, R.D.,Slack, J.E., Mager, D.E., and Straubinger, R., and Arnold, Robert D
AAPS National Meeting, Baltimore, MD. 2004. | Conference Proceeding
 
Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy
Arnold, Robert DArnold, Robert DSlack, Jeanine ESlack, Jeanine EStraubinger, Robert M and Straubinger, Robert M
Journal of Chromatography B, vol. 808, (no. 2), pp. 152, 2004. | Journal Article
 
Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.
Arnold, Robert DArnold, Robert DSlack, Jeanine ESlack, Jeanine EStraubinger, Robert M and Straubinger, Robert M
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, vol. 808, (no. 2), pp. 141-52, 2004/Sep/5. | Journal Article
 
Tumor antivascular effects of liposome-incorporated drugs (Dissertation)
Arnold, Robert D (2004).
 
Tumor Antivascular Effects of Liposome-Incorporated Drugs
Arnold, Robert D
Spring 2004
2003
Analysis of doxorubicin in rat tissues by liquid chromatography tandem mass spectroscopy (LC-MS/MS)
Arnold, R.D.,Slack, J.E., and Straubinger R.M. and Arnold, Robert D
AAPS National Meeting, Salt Lake City, UT. 2003. | Conference Proceeding
 
Antivascular effect of doxorubicin liposomes in a rat brain tumor model
Arnold, R.D.,Slack, J.E., Zhou, R., Mazurchuk, Chau, R.I., and Straubinger R.M. and Arnold, Robert D
AAPS National Meeting, Salt Lake City, UT. 2003. | Conference Proceeding
n.d.no date or unknown
Enhanced tumor vascular permeability with repetitive administration of doxorubicin-containing liposomes in a rat brain tumor model
Arnold, Robert D and Slack, J.E., and Straubinger R.M.
. | Journal Article
 
Liposomal formulation of TNP-470 and plasma stability
Arnold, R.D., Balasubramanian, S., Straubinger, R.M and Arnold, Robert D
. | Journal Article